This site is intended for health professionals only

Home
>
Editor’s pick

Editor’s pick

Lundbeck acquire technologies to treat brain damage

Lundbeck acquire technologies to treat brain damage

Novartis commits to reducing TB in Tanzania

Novartis commits to reducing TB in Tanzania

Drug effective against facial pain

Drug effective against facial pain

FDA approves Multaq heart tablet

FDA approves Multaq heart tablet

Study shows early and sustained improvement in vision through six months

Study shows early and sustained improvement in vision through six months

Black box warning for smoking drugs

Black box warning for smoking drugs

AstraZeneca’s Iressa approved in Europe

AstraZeneca’s Iressa approved in Europe

Report recommends statins for all

Report recommends statins for all

Sutent fails in colon-cancer trial

Sutent fails in colon-cancer trial

Doing more with less – IT and automation are the way forward

Doing more with less – IT and automation are the way forward

New data on lacosamide presented at International Epilepsy Congress today

New data on lacosamide presented at International Epilepsy Congress today

Still no treatment for lung disease

Still no treatment for lung disease

« Previous 1 … 127 128 129 130 131 … 302 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x